Information on cost-effectiveness

An essential product of a national comparative effectiveness program

Neil Kirschner, Stephen G. Pauker, Joseph W. Stubbs, Mary M. Newman, Peter Basch, Yul D. Ejnes, Jeannine Z. Engel, Stephen D. Fihn, Susan H. Gunn, William (Bill) Hersh, Michael D. Lahey, J. Leonard Lichtenfeld, Eric M. Mazur, Michael C. Sha

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

The American College of Physicians recently highlighted the need to provide increased information comparing the effectiveness of health care interventions to ensure the rational and effective practice of medicine. Comparative effectiveness refers to the evaluation of the relative clinical effectiveness, safety, and cost of 2 or more medical services, drugs, devices, therapies, or procedures used to treat the same condition. The College further recommended the establishment of an adequately funded, trusted national entity that should prioritize, sponsor, or produce both comparative clinical and cost-effectiveness data. This article addresses the need for the proposed entity to develop cost-effectiveness information. It examines the current reluctance to develop and use cost-effectiveness in the United States; it argues for the importance of this information for all health care stakeholders; and it makes specific recommendations regarding how this information can best be made available and used for the good of the public and our patients.

Original languageEnglish (US)
Pages (from-to)956-961
Number of pages6
JournalAnnals of Internal Medicine
Volume148
Issue number12
StatePublished - Jun 17 2008
Externally publishedYes

Fingerprint

Program Evaluation
Cost-Benefit Analysis
Delivery of Health Care
Medicine
Physicians
Safety
Costs and Cost Analysis
Drug Therapy
Equipment and Supplies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kirschner, N., Pauker, S. G., Stubbs, J. W., Newman, M. M., Basch, P., Ejnes, Y. D., ... Sha, M. C. (2008). Information on cost-effectiveness: An essential product of a national comparative effectiveness program. Annals of Internal Medicine, 148(12), 956-961.

Information on cost-effectiveness : An essential product of a national comparative effectiveness program. / Kirschner, Neil; Pauker, Stephen G.; Stubbs, Joseph W.; Newman, Mary M.; Basch, Peter; Ejnes, Yul D.; Engel, Jeannine Z.; Fihn, Stephen D.; Gunn, Susan H.; Hersh, William (Bill); Lahey, Michael D.; Lichtenfeld, J. Leonard; Mazur, Eric M.; Sha, Michael C.

In: Annals of Internal Medicine, Vol. 148, No. 12, 17.06.2008, p. 956-961.

Research output: Contribution to journalArticle

Kirschner, N, Pauker, SG, Stubbs, JW, Newman, MM, Basch, P, Ejnes, YD, Engel, JZ, Fihn, SD, Gunn, SH, Hersh, WB, Lahey, MD, Lichtenfeld, JL, Mazur, EM & Sha, MC 2008, 'Information on cost-effectiveness: An essential product of a national comparative effectiveness program', Annals of Internal Medicine, vol. 148, no. 12, pp. 956-961.
Kirschner N, Pauker SG, Stubbs JW, Newman MM, Basch P, Ejnes YD et al. Information on cost-effectiveness: An essential product of a national comparative effectiveness program. Annals of Internal Medicine. 2008 Jun 17;148(12):956-961.
Kirschner, Neil ; Pauker, Stephen G. ; Stubbs, Joseph W. ; Newman, Mary M. ; Basch, Peter ; Ejnes, Yul D. ; Engel, Jeannine Z. ; Fihn, Stephen D. ; Gunn, Susan H. ; Hersh, William (Bill) ; Lahey, Michael D. ; Lichtenfeld, J. Leonard ; Mazur, Eric M. ; Sha, Michael C. / Information on cost-effectiveness : An essential product of a national comparative effectiveness program. In: Annals of Internal Medicine. 2008 ; Vol. 148, No. 12. pp. 956-961.
@article{4debcbe7ca144d3f860cd1ea422addd1,
title = "Information on cost-effectiveness: An essential product of a national comparative effectiveness program",
abstract = "The American College of Physicians recently highlighted the need to provide increased information comparing the effectiveness of health care interventions to ensure the rational and effective practice of medicine. Comparative effectiveness refers to the evaluation of the relative clinical effectiveness, safety, and cost of 2 or more medical services, drugs, devices, therapies, or procedures used to treat the same condition. The College further recommended the establishment of an adequately funded, trusted national entity that should prioritize, sponsor, or produce both comparative clinical and cost-effectiveness data. This article addresses the need for the proposed entity to develop cost-effectiveness information. It examines the current reluctance to develop and use cost-effectiveness in the United States; it argues for the importance of this information for all health care stakeholders; and it makes specific recommendations regarding how this information can best be made available and used for the good of the public and our patients.",
author = "Neil Kirschner and Pauker, {Stephen G.} and Stubbs, {Joseph W.} and Newman, {Mary M.} and Peter Basch and Ejnes, {Yul D.} and Engel, {Jeannine Z.} and Fihn, {Stephen D.} and Gunn, {Susan H.} and Hersh, {William (Bill)} and Lahey, {Michael D.} and Lichtenfeld, {J. Leonard} and Mazur, {Eric M.} and Sha, {Michael C.}",
year = "2008",
month = "6",
day = "17",
language = "English (US)",
volume = "148",
pages = "956--961",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "12",

}

TY - JOUR

T1 - Information on cost-effectiveness

T2 - An essential product of a national comparative effectiveness program

AU - Kirschner, Neil

AU - Pauker, Stephen G.

AU - Stubbs, Joseph W.

AU - Newman, Mary M.

AU - Basch, Peter

AU - Ejnes, Yul D.

AU - Engel, Jeannine Z.

AU - Fihn, Stephen D.

AU - Gunn, Susan H.

AU - Hersh, William (Bill)

AU - Lahey, Michael D.

AU - Lichtenfeld, J. Leonard

AU - Mazur, Eric M.

AU - Sha, Michael C.

PY - 2008/6/17

Y1 - 2008/6/17

N2 - The American College of Physicians recently highlighted the need to provide increased information comparing the effectiveness of health care interventions to ensure the rational and effective practice of medicine. Comparative effectiveness refers to the evaluation of the relative clinical effectiveness, safety, and cost of 2 or more medical services, drugs, devices, therapies, or procedures used to treat the same condition. The College further recommended the establishment of an adequately funded, trusted national entity that should prioritize, sponsor, or produce both comparative clinical and cost-effectiveness data. This article addresses the need for the proposed entity to develop cost-effectiveness information. It examines the current reluctance to develop and use cost-effectiveness in the United States; it argues for the importance of this information for all health care stakeholders; and it makes specific recommendations regarding how this information can best be made available and used for the good of the public and our patients.

AB - The American College of Physicians recently highlighted the need to provide increased information comparing the effectiveness of health care interventions to ensure the rational and effective practice of medicine. Comparative effectiveness refers to the evaluation of the relative clinical effectiveness, safety, and cost of 2 or more medical services, drugs, devices, therapies, or procedures used to treat the same condition. The College further recommended the establishment of an adequately funded, trusted national entity that should prioritize, sponsor, or produce both comparative clinical and cost-effectiveness data. This article addresses the need for the proposed entity to develop cost-effectiveness information. It examines the current reluctance to develop and use cost-effectiveness in the United States; it argues for the importance of this information for all health care stakeholders; and it makes specific recommendations regarding how this information can best be made available and used for the good of the public and our patients.

UR - http://www.scopus.com/inward/record.url?scp=45549088555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549088555&partnerID=8YFLogxK

M3 - Article

VL - 148

SP - 956

EP - 961

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 12

ER -